| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 5.24e-05 | 2 | 145 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | GTP binding | RAB35 RAB8B ACSM1 RAB40A RAB8A EHD4 UCP1 RAB40AL RAB1B RAB40B RAB13 | 1.56e-04 | 397 | 145 | 11 | GO:0005525 |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 1.96e-04 | 16 | 145 | 3 | GO:0034236 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB35 RAB8B ACSM1 RAB40A RAB8A EHD4 UCP1 RAB40AL RAB1B RAB40B RAB13 | 3.70e-04 | 439 | 145 | 11 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB35 RAB8B ACSM1 RAB40A RAB8A EHD4 UCP1 RAB40AL RAB1B RAB40B RAB13 | 3.70e-04 | 439 | 145 | 11 | GO:0019001 |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 5.16e-04 | 5 | 145 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB35 ERCC6 RAB8B MCM5 RAB40A ATP13A2 KIF20B RAB8A SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 HSP90AA4P | 5.25e-04 | 775 | 145 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH11 MYO6 PSG5 EML4 FERMT1 EPB41L5 DCX POF1B KIF20B GSK3A RAB8A NF1 SMC3 TLN2 EML1 TRIM36 STK38L FYN | 1.04e-03 | 1099 | 145 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | amidine-lyase activity | 1.07e-03 | 7 | 145 | 2 | GO:0016842 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.07e-03 | 7 | 145 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB35 ERCC6 RAB8B MCM5 RAB40A ATP13A2 KIF20B RAB8A SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 HSP90AA4P | 1.17e-03 | 839 | 145 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB35 ERCC6 RAB8B MCM5 RAB40A ATP13A2 KIF20B RAB8A SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 HSP90AA4P | 1.19e-03 | 840 | 145 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB35 ERCC6 RAB8B MCM5 RAB40A ATP13A2 KIF20B RAB8A SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 HSP90AA4P | 1.19e-03 | 840 | 145 | 15 | GO:0016818 |
| GeneOntologyCellularComponent | transport vesicle | RAB35 COPA SYT3 WDR7 RAB8B PDYN DBH RAB40A ATP13A2 RAB8A FURIN RAB40AL MTMR2 RAB1B RAB40B RAB13 | 5.57e-07 | 519 | 143 | 16 | GO:0030133 |
| GeneOntologyCellularComponent | exocytic vesicle | RAB35 SYT3 WDR7 RAB8B PDYN RAB40A RAB8A RAB40AL MTMR2 RAB40B RAB13 | 1.31e-05 | 320 | 143 | 11 | GO:0070382 |
| GeneOntologyCellularComponent | cell projection membrane | EPS15 RAB35 MYO6 PSG5 FERMT1 EPB41L5 BBS2 ITLN2 RAB8A PLEK2 ENPEP SLC27A4 | 4.22e-05 | 431 | 143 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | synaptic vesicle | RAB35 WDR7 RAB8B PDYN RAB40A RAB8A RAB40AL MTMR2 RAB40B RAB13 | 4.25e-05 | 300 | 143 | 10 | GO:0008021 |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 1.58e-04 | 40 | 143 | 4 | GO:0030140 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHA6 DSCAM COPA MYO6 PDYN LAMA2 DBH ATP13A2 DCX TENM2 GSK3A RAB8A NF1 P2RX2 SCN1A MTMR2 WDFY3 FYN HOMER3 HSP90AA4P | 2.67e-04 | 1228 | 143 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | phagophore assembly site membrane | 4.39e-04 | 22 | 143 | 3 | GO:0034045 | |
| GeneOntologyCellularComponent | endosome | EPS15 RAB35 SYT3 MYO6 RAB8B RAB40A ATP13A2 RAB8A EHD4 FURIN RAB40AL RNFT1 MTMR2 TAB1 RAB40B HAS3 FYN RAB13 | 1.04e-03 | 1167 | 143 | 18 | GO:0005768 |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.04e-03 | 112 | 143 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | presynapse | RAB35 MYO6 WDR7 RAB8B PDYN DBH RAB40A RAB8A NF1 P2RX2 SCN1A RAB40AL MTMR2 RAB40B RAB13 | 1.11e-03 | 886 | 143 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.13e-03 | 114 | 143 | 5 | GO:0005798 | |
| GeneOntologyCellularComponent | axon | TSHZ3 DSCAM COPA MYO6 PDYN DBH DCX TENM2 KIF20B GSK3A NF1 P2RX2 SCN1A MTMR2 WDFY3 | 1.18e-03 | 891 | 143 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.25e-03 | 237 | 143 | 7 | GO:0030136 | |
| GeneOntologyCellularComponent | glutamatergic synapse | EPS15 MYO6 ADGRB2 STK38 DCX TENM2 RAB8A TENM4 NF1 P2RX2 DROSHA STK38L FYN HOMER3 | 1.46e-03 | 817 | 143 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | DSCAM COPA MYO6 PDYN DBH ATP13A2 DCX GSK3A RAB8A P2RX2 SCN1A WDFY3 FYN HSP90AA4P | 1.79e-03 | 835 | 143 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | DAOA MYO6 RAB8B RAB40A KIF20B RYR3 EHD4 RAB40AL MTMR2 TENM1 RAB1B RAB40B EML1 FYN HSP90AA4P | 1.87e-03 | 934 | 143 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | dendrite | EPHA6 DSCAM PDYN LAMA2 DBH DCX TENM2 GSK3A RAB8A NF1 P2RX2 MTMR2 FYN HOMER3 | 2.29e-03 | 858 | 143 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHA6 DSCAM PDYN LAMA2 DBH DCX TENM2 GSK3A RAB8A NF1 P2RX2 MTMR2 FYN HOMER3 | 2.34e-03 | 860 | 143 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | phagophore assembly site | 2.39e-03 | 39 | 143 | 3 | GO:0000407 | |
| Domain | RAB | 8.12e-08 | 73 | 142 | 8 | PS51419 | |
| Domain | Tox-GHH_dom | 1.71e-06 | 4 | 142 | 3 | IPR028916 | |
| Domain | Tox-GHH | 1.71e-06 | 4 | 142 | 3 | PF15636 | |
| Domain | Ten_N | 1.71e-06 | 4 | 142 | 3 | IPR009471 | |
| Domain | Ten_N | 1.71e-06 | 4 | 142 | 3 | PF06484 | |
| Domain | TENEURIN_N | 1.71e-06 | 4 | 142 | 3 | PS51361 | |
| Domain | YD | 4.26e-06 | 5 | 142 | 3 | IPR006530 | |
| Domain | Ras | 9.51e-06 | 136 | 142 | 8 | PF00071 | |
| Domain | Quino_amine_DH_bsu | 2.11e-05 | 22 | 142 | 4 | IPR011044 | |
| Domain | Small_GTPase | 3.09e-05 | 160 | 142 | 8 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 4.20e-05 | 167 | 142 | 8 | IPR005225 | |
| Domain | Fibrinogen_C | 4.91e-05 | 27 | 142 | 4 | PF00147 | |
| Domain | FBG | 6.56e-05 | 29 | 142 | 4 | SM00186 | |
| Domain | - | 7.53e-05 | 30 | 142 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 7.53e-05 | 30 | 142 | 4 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 9.76e-05 | 32 | 142 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 9.76e-05 | 32 | 142 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 9.76e-05 | 32 | 142 | 4 | PS51406 | |
| Domain | NHL | 1.16e-04 | 13 | 142 | 3 | PS51125 | |
| Domain | Rhs_assc_core | 1.71e-04 | 3 | 142 | 2 | IPR022385 | |
| Domain | P-loop_NTPase | RAB35 MYH11 ERCC6 MYO6 RAB8B MCM5 RAB40A TEP1 KIF20B RAB8A EHD4 SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 | 2.47e-04 | 848 | 142 | 17 | IPR027417 |
| Domain | Gal_mutarotase_N | 3.41e-04 | 4 | 142 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 3.41e-04 | 4 | 142 | 2 | PF16863 | |
| Domain | SOCS | 4.46e-04 | 20 | 142 | 3 | SM00253 | |
| Domain | Fibrinogen_a/b/g_C_2 | 7.75e-04 | 24 | 142 | 3 | IPR014715 | |
| Domain | - | 7.75e-04 | 24 | 142 | 3 | 4.10.530.10 | |
| Domain | SPOC_C | 8.44e-04 | 6 | 142 | 2 | IPR012921 | |
| Domain | Glyco_hydro_31_AS | 8.44e-04 | 6 | 142 | 2 | IPR030458 | |
| Domain | HELP | 8.44e-04 | 6 | 142 | 2 | PF03451 | |
| Domain | HELP | 8.44e-04 | 6 | 142 | 2 | IPR005108 | |
| Domain | SPOC | 8.44e-04 | 6 | 142 | 2 | PF07744 | |
| Domain | - | 1.03e-03 | 333 | 142 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.07e-03 | 335 | 142 | 9 | IPR015943 | |
| Domain | Glyco_hydro_31 | 1.18e-03 | 7 | 142 | 2 | IPR000322 | |
| Domain | TFS2M | 1.18e-03 | 7 | 142 | 2 | SM00510 | |
| Domain | Glyco_hydro_31 | 1.18e-03 | 7 | 142 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.18e-03 | 7 | 142 | 2 | PS00129 | |
| Domain | TFIIS_M | 1.18e-03 | 7 | 142 | 2 | PF07500 | |
| Domain | ERAP1-like_C_dom | 1.56e-03 | 8 | 142 | 2 | IPR024571 | |
| Domain | TFIIS_cen_dom | 1.56e-03 | 8 | 142 | 2 | IPR003618 | |
| Domain | ERAP1_C | 1.56e-03 | 8 | 142 | 2 | PF11838 | |
| Domain | - | 1.56e-03 | 8 | 142 | 2 | 1.10.472.30 | |
| Domain | Trefoil | 1.56e-03 | 8 | 142 | 2 | PF00088 | |
| Domain | LAMININ_IVA | 1.56e-03 | 8 | 142 | 2 | PS51115 | |
| Domain | Laminin_B | 1.56e-03 | 8 | 142 | 2 | PF00052 | |
| Domain | TFIIS_CENTRAL | 1.56e-03 | 8 | 142 | 2 | PS51321 | |
| Domain | LamB | 1.56e-03 | 8 | 142 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.56e-03 | 8 | 142 | 2 | IPR000034 | |
| Domain | - | RAB35 ERCC6 RAB8B MCM5 RAB40A TEP1 RAB8A EHD4 SMC3 RAB40AL RAB1B RAB40B DHX29 RAB13 | 1.66e-03 | 746 | 142 | 14 | 3.40.50.300 |
| Domain | FERM_N | 1.99e-03 | 33 | 142 | 3 | IPR018979 | |
| Domain | FERM_N | 1.99e-03 | 33 | 142 | 3 | PF09379 | |
| Domain | P_TREFOIL_2 | 2.00e-03 | 9 | 142 | 2 | PS51448 | |
| Domain | PD | 2.00e-03 | 9 | 142 | 2 | SM00018 | |
| Domain | IGc2 | 2.16e-03 | 235 | 142 | 7 | SM00408 | |
| Domain | Ig_sub2 | 2.16e-03 | 235 | 142 | 7 | IPR003598 | |
| Domain | EF-hand_4 | 2.48e-03 | 10 | 142 | 2 | PF12763 | |
| Domain | SOCS_box | 2.99e-03 | 38 | 142 | 3 | PF07525 | |
| Domain | - | 3.02e-03 | 11 | 142 | 2 | 4.10.110.10 | |
| Domain | Laminin_G_1 | 3.02e-03 | 11 | 142 | 2 | PF00054 | |
| Domain | EH | 3.02e-03 | 11 | 142 | 2 | PS50031 | |
| Domain | EH | 3.02e-03 | 11 | 142 | 2 | SM00027 | |
| Domain | EH_dom | 3.02e-03 | 11 | 142 | 2 | IPR000261 | |
| Domain | SOCS_box | 3.22e-03 | 39 | 142 | 3 | SM00969 | |
| Domain | SOCS_box | 3.22e-03 | 39 | 142 | 3 | IPR001496 | |
| Domain | - | 3.22e-03 | 39 | 142 | 3 | 2.120.10.30 | |
| Domain | SOCS | 3.22e-03 | 39 | 142 | 3 | PS50225 | |
| Domain | P_trefoil_dom | 3.60e-03 | 12 | 142 | 2 | IPR000519 | |
| Domain | Peptidase_M1 | 3.60e-03 | 12 | 142 | 2 | IPR001930 | |
| Domain | - | 4.24e-03 | 13 | 142 | 2 | 1.20.58.280 | |
| Domain | Peptidase_M1_N | 4.24e-03 | 13 | 142 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 4.24e-03 | 13 | 142 | 2 | PF01433 | |
| Domain | MIT | 4.92e-03 | 14 | 142 | 2 | IPR007330 | |
| Domain | SEA | 4.92e-03 | 14 | 142 | 2 | SM00200 | |
| Domain | FERM_M | 5.14e-03 | 46 | 142 | 3 | PF00373 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.14e-03 | 46 | 142 | 3 | IPR011042 | |
| Domain | WD_REPEATS_1 | 5.43e-03 | 278 | 142 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.53e-03 | 279 | 142 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.53e-03 | 279 | 142 | 7 | PS50294 | |
| Domain | - | 6.14e-03 | 49 | 142 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 6.14e-03 | 49 | 142 | 3 | IPR019748 | |
| Domain | FERM_domain | 6.14e-03 | 49 | 142 | 3 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 6.50e-03 | 50 | 142 | 3 | IPR014352 | |
| Domain | FERM_1 | 6.50e-03 | 50 | 142 | 3 | PS00660 | |
| Domain | FERM_2 | 6.50e-03 | 50 | 142 | 3 | PS00661 | |
| Domain | FERM_3 | 6.50e-03 | 50 | 142 | 3 | PS50057 | |
| Domain | Band_41_domain | 6.50e-03 | 50 | 142 | 3 | IPR019749 | |
| Domain | B41 | 6.50e-03 | 50 | 142 | 3 | SM00295 | |
| Domain | Gal_mutarotase_SF_dom | 7.24e-03 | 17 | 142 | 2 | IPR011013 | |
| Domain | CarboxyPept-like_regulatory | 7.24e-03 | 17 | 142 | 2 | IPR008969 | |
| Domain | AMP-bd_C | 7.24e-03 | 17 | 142 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 7.24e-03 | 17 | 142 | 2 | PF13193 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 2.77e-08 | 65 | 106 | 8 | MM15511 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 5.42e-07 | 65 | 106 | 7 | M27771 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 4.98e-06 | 90 | 106 | 7 | M27779 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 5.37e-06 | 91 | 106 | 7 | MM15518 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | IGHV3-53 EPS15 RAB35 COPA MYO6 RAB8B KIF20B RAB8A NBAS COG6 RAB3GAP2 HPS1 RAB1B RAB13 IGHV3-66 IGHV3-64 | 2.43e-05 | 645 | 106 | 16 | MM15232 |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 2.96e-05 | 118 | 106 | 7 | MM15589 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 3.67e-05 | 122 | 106 | 7 | M27872 | |
| Pubmed | 2.16e-10 | 61 | 148 | 8 | 12578829 | ||
| Pubmed | 8.45e-10 | 72 | 148 | 8 | 16923123 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC6 DSC3 COPA MYO6 EML4 FERMT1 SRM EPB41L5 MCM5 ELP3 KIF20B EHD4 NUP205 PLEK2 NF1 ADSL SMC3 MAP4K5 WDFY3 RIOK2 DHX29 RAB13 SLC27A4 FTSJ3 | 3.18e-09 | 1353 | 148 | 24 | 29467282 |
| Pubmed | 5.49e-09 | 58 | 148 | 7 | 11856727 | ||
| Pubmed | 8.86e-09 | 62 | 148 | 7 | 11773082 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 2.17e-08 | 8 | 148 | 4 | 12634303 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 3.01e-07 | 4 | 148 | 3 | 10225957 | |
| Pubmed | Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. | 3.01e-07 | 4 | 148 | 3 | 26471730 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 24213529 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 3.01e-07 | 4 | 148 | 3 | 12000766 | |
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 5.09e-07 | 37 | 148 | 5 | 20937701 | |
| Pubmed | 5.69e-07 | 225 | 148 | 9 | 12168954 | ||
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 27909076 | ||
| Pubmed | 8.77e-07 | 237 | 148 | 9 | 29564676 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 12915301 | ||
| Pubmed | 2.62e-06 | 23 | 148 | 4 | 20360680 | ||
| Pubmed | 4.16e-06 | 8 | 148 | 3 | 10331952 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 5.38e-06 | 377 | 148 | 10 | 38117590 | |
| Pubmed | 8.87e-06 | 10 | 148 | 3 | 38713721 | ||
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | RAB35 ATG2B SRM TNS2 KEAP1 ELP3 RAB8A NUP205 ADSL MTMR2 TAB1 RAB13 SLC27A4 RPAP2 FTSJ3 | 1.12e-05 | 931 | 148 | 15 | 27432908 |
| Pubmed | 1.54e-05 | 257 | 148 | 8 | 16335952 | ||
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 1.80e-05 | 2 | 148 | 2 | 25601544 | |
| Pubmed | Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development. | 1.80e-05 | 2 | 148 | 2 | 19776266 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8621634 | ||
| Pubmed | Teneurin-2 (TENM2) deficiency induces UCP1 expression in differentiating human fat cells. | 1.80e-05 | 2 | 148 | 2 | 28088466 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8294494 | ||
| Pubmed | Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer. | 1.80e-05 | 2 | 148 | 2 | 20503398 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22445341 | ||
| Pubmed | FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation. | 1.80e-05 | 2 | 148 | 2 | 30683885 | |
| Pubmed | Isoprenylation of Rab proteins possessing a C-terminal CaaX motif. | 1.80e-05 | 2 | 148 | 2 | 8375503 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15037617 | ||
| Pubmed | MXRA5 MYO6 TNC REV3L FER1L6 RAB8A ARID1B NF1 RAB1B WDFY3 HOMER3 IGSF3 | 1.98e-05 | 638 | 148 | 12 | 31182584 | |
| Pubmed | 2.09e-05 | 13 | 148 | 3 | 26833786 | ||
| Pubmed | 2.66e-05 | 14 | 148 | 3 | 10575223 | ||
| Pubmed | 2.73e-05 | 363 | 148 | 9 | 25036637 | ||
| Pubmed | 3.31e-05 | 15 | 148 | 3 | 19793892 | ||
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 3.31e-05 | 15 | 148 | 3 | 12657787 | |
| Pubmed | Cytoplasmic control of Rab family small GTPases through BAG6. | 3.31e-05 | 15 | 148 | 3 | 30804014 | |
| Pubmed | RAB35 MYH11 COPA RAB8B STK38 MCM5 RAB8A ARID1B SMC3 SCN1A RAB1B STK38L FYN DHX29 HSP90AA4P FTSJ3 | 3.49e-05 | 1153 | 148 | 16 | 29845934 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPS15 EML4 STK38 TNS2 POF1B GSK3A ULK3 NF1 MAP4K5 AKAP11 TAB1 STK38L RIOK2 FYN | 3.68e-05 | 910 | 148 | 14 | 36736316 |
| Pubmed | 4.47e-05 | 46 | 148 | 4 | 30659120 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.52e-05 | 91 | 148 | 5 | 28558017 | |
| Pubmed | 4.91e-05 | 17 | 148 | 3 | 37042948 | ||
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 5.38e-05 | 3 | 148 | 2 | 21262772 | |
| Pubmed | Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. | 5.38e-05 | 3 | 148 | 2 | 21041651 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 23897809 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 32503983 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 12221131 | ||
| Pubmed | GSK3 is a negative regulator of the thermogenic program in brown adipocytes. | 5.38e-05 | 3 | 148 | 2 | 29472592 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 28076793 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 22011575 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 31707148 | ||
| Pubmed | Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. | 5.38e-05 | 3 | 148 | 2 | 15280392 | |
| Pubmed | HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. | 5.38e-05 | 3 | 148 | 2 | 15582665 | |
| Pubmed | EPS15 DSC3 COPA MYO6 ATG2B STK38 EPB41L5 KEAP1 SMC3 MAP4K5 RAB3GAP2 DHX29 | 5.42e-05 | 708 | 148 | 12 | 39231216 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH11 COPA MYO6 RAB8B EPB41L5 MCM5 RAB8A SMC3 RAB1B RIOK2 FYN RAB13 HSP90AA4P FTSJ3 | 5.77e-05 | 949 | 148 | 14 | 36574265 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 5.80e-05 | 498 | 148 | 10 | 36634849 | |
| Pubmed | RAB35 DSC3 COPA MYO6 WDR7 SRM EPB41L5 MCM5 EHD4 NUP205 SMC3 FURIN AKAP11 RAB13 | 5.97e-05 | 952 | 148 | 14 | 38569033 | |
| Pubmed | EPS15 DSCAM SYT3 WDR7 ADGRB2 KEAP1 DCX TENM2 NF1 LDB1 TLN2 WDFY3 EML1 HOMER3 | 6.74e-05 | 963 | 148 | 14 | 28671696 | |
| Pubmed | 6.76e-05 | 99 | 148 | 5 | 31723608 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TMEM186 EPB41L5 TNS2 MCM5 ELP3 POF1B NUP205 ADSL SMC3 MTMR2 TAB1 DHX29 SLC27A4 HSP90AA4P | 7.61e-05 | 974 | 148 | 14 | 28675297 |
| Pubmed | 9.49e-05 | 21 | 148 | 3 | 32591430 | ||
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 1.07e-04 | 4 | 148 | 2 | 26637798 | |
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 19062280 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 22260870 | ||
| Pubmed | MICAL-L1 is a tubular endosomal membrane hub that connects Rab35 and Arf6 with Rab8a. | 1.07e-04 | 4 | 148 | 2 | 21951725 | |
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 9030196 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 20161783 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 33057193 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 1.07e-04 | 4 | 148 | 2 | 15197186 | |
| Pubmed | Chaperone-assisted production of active human Rab8A GTPase in Escherichia coli. | 1.07e-04 | 4 | 148 | 2 | 19116169 | |
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 36438572 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 17999179 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 34504132 | ||
| Pubmed | Rab40C is a novel Varp-binding protein that promotes proteasomal degradation of Varp in melanocytes. | 1.07e-04 | 4 | 148 | 2 | 25661869 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.10e-04 | 22 | 148 | 3 | 2499654 | |
| Pubmed | RAB35 ATG2B ADGRB2 TENM2 GSK3A TENM4 NF1 SCN1A RAB3GAP2 TENM1 TLN2 RAB1B TAB1 DHX29 IGSF3 | 1.11e-04 | 1139 | 148 | 15 | 36417873 | |
| Pubmed | 1.13e-04 | 437 | 148 | 9 | 20562859 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.62e-04 | 25 | 148 | 3 | 19373938 | |
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 23991058 | ||
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 18094055 | ||
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 23435566 | ||
| Pubmed | Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases. | 1.78e-04 | 5 | 148 | 2 | 15067004 | |
| Pubmed | A single-vector intersectional AAV strategy for interrogating cellular diversity and brain function. | 1.78e-04 | 5 | 148 | 2 | 38802592 | |
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 26821125 | ||
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 12084815 | ||
| Pubmed | Ndr kinases regulate retinal interneuron proliferation and homeostasis. | 1.78e-04 | 5 | 148 | 2 | 30135513 | |
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 15971998 | ||
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 15837803 | ||
| Pubmed | 1.78e-04 | 5 | 148 | 2 | 9915576 | ||
| Pubmed | MICAL-like1 mediates epidermal growth factor receptor endocytosis. | 1.78e-04 | 5 | 148 | 2 | 21795389 | |
| Pubmed | A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1. | 1.78e-04 | 5 | 148 | 2 | 21378754 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | COPA MYO6 MCM5 KEAP1 EHD4 NUP205 NBAS SMC3 RAB3GAP2 RAB1B DHX29 | 2.26e-04 | 704 | 148 | 11 | 29955894 |
| Pubmed | 2.33e-04 | 591 | 148 | 10 | 15231748 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPS15 RAB35 DSC3 COPA ERAP1 RAB8B NTMT1 MCM5 KEAP1 EHD4 NUP205 PARP10 RAB1B DHX29 RAB13 SLC27A4 | 2.49e-04 | 1367 | 148 | 16 | 32687490 |
| Pubmed | Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration. | 2.67e-04 | 6 | 148 | 2 | 36446521 | |
| Pubmed | 2.67e-04 | 6 | 148 | 2 | 18562329 | ||
| Pubmed | MICAL-L1 links EHD1 to tubular recycling endosomes and regulates receptor recycling. | 2.67e-04 | 6 | 148 | 2 | 19864458 | |
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 2.67e-04 | 6 | 148 | 2 | 22925892 | |
| Pubmed | 2.67e-04 | 6 | 148 | 2 | 22685302 | ||
| Interaction | ANKRD20A4P interactions | 7.18e-06 | 6 | 145 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 1.25e-05 | 7 | 145 | 3 | int:ANKRD20A2P | |
| GeneFamily | RAB, member RAS oncogene GTPases | 1.03e-07 | 65 | 106 | 7 | 388 | |
| GeneFamily | Fibrinogen C domain containing | 1.28e-05 | 25 | 106 | 4 | 554 | |
| GeneFamily | Immunoglobulin like domain containing | 1.42e-04 | 193 | 106 | 7 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 7.01e-04 | 7 | 106 | 2 | 570 | |
| GeneFamily | Fibronectin type III domain containing | 2.52e-03 | 160 | 106 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.59e-03 | 161 | 106 | 5 | 593 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.14e-03 | 50 | 106 | 3 | 1293 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.33e-03 | 51 | 106 | 3 | 870 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.37e-03 | 17 | 106 | 2 | 104 | |
| GeneFamily | WD repeat domain containing | 4.46e-03 | 262 | 106 | 6 | 362 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 1.95e-06 | 199 | 147 | 9 | M6157 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.36e-07 | 190 | 147 | 8 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-06 | 174 | 147 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.78e-06 | 185 | 147 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P FGL2 TENM4 ANKRD20A4P ANKRD20A1 | 2.88e-06 | 186 | 147 | 7 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-06 | 187 | 147 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P TENM4 ANKRD20A4P FYN ANKRD20A1 | 3.09e-06 | 188 | 147 | 7 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.94e-06 | 195 | 147 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-06 | 196 | 147 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-06 | 196 | 147 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-06 | 197 | 147 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-06 | 197 | 147 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-06 | 197 | 147 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-06 | 197 | 147 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-06 | 197 | 147 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.50e-06 | 199 | 147 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.90e-06 | 131 | 147 | 6 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-05 | 152 | 147 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 169 | 147 | 6 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-05 | 176 | 147 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-05 | 176 | 147 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-05 | 177 | 147 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-05 | 177 | 147 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.38e-05 | 184 | 147 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 184 | 147 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.48e-05 | 185 | 147 | 6 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 3.59e-05 | 186 | 147 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 188 | 147 | 6 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 3.81e-05 | 188 | 147 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 189 | 147 | 6 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-05 | 190 | 147 | 6 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-05 | 190 | 147 | 6 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.04e-05 | 190 | 147 | 6 | 373629dde5eda722424c5e6087763f0c5db67cf4 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.16e-05 | 191 | 147 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.29e-05 | 192 | 147 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 192 | 147 | 6 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 192 | 147 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.41e-05 | 193 | 147 | 6 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 193 | 147 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 193 | 147 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.54e-05 | 194 | 147 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 194 | 147 | 6 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.67e-05 | 195 | 147 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.67e-05 | 195 | 147 | 6 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-05 | 196 | 147 | 6 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-05 | 196 | 147 | 6 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-05 | 196 | 147 | 6 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.81e-05 | 196 | 147 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-05 | 196 | 147 | 6 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.95e-05 | 197 | 147 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.95e-05 | 197 | 147 | 6 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.95e-05 | 197 | 147 | 6 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-05 | 198 | 147 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-05 | 198 | 147 | 6 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-05 | 198 | 147 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-05 | 198 | 147 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 147 | 6 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 199 | 147 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 199 | 147 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-05 | 200 | 147 | 6 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.38e-05 | 200 | 147 | 6 | 7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.38e-05 | 200 | 147 | 6 | af57f837eb7f988d24fc4612d16d68121498f0b0 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 5.38e-05 | 200 | 147 | 6 | 09deb831fc2c8a8867cc850f3aa094a5e48489ff | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.38e-05 | 200 | 147 | 6 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | proximal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.38e-05 | 200 | 147 | 6 | 9c7859659843b1566bdf623b269b5e166c89d38c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.38e-05 | 200 | 147 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-05 | 132 | 147 | 5 | 182973660929fe4174e0354c85863a25518c18c1 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 145 | 147 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 149 | 147 | 5 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 151 | 147 | 5 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 153 | 147 | 5 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 156 | 147 | 5 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 156 | 147 | 5 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | ASK452-Epithelial-Type_2|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.69e-04 | 156 | 147 | 5 | e2b8d65c38cedb8ec6c3c1b138957145af931c51 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 160 | 147 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 160 | 147 | 5 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 160 | 147 | 5 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 160 | 147 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-04 | 166 | 147 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-04 | 166 | 147 | 5 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.32e-04 | 167 | 147 | 5 | 01c42e555913b17e62846325cc17b3d8f92da1e1 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 167 | 147 | 5 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-04 | 169 | 147 | 5 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-04 | 169 | 147 | 5 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-04 | 170 | 147 | 5 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 3.08e-06 | 187 | 144 | 9 | 2669_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A | 3.66e-06 | 191 | 144 | 9 | 2466_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.66e-06 | 191 | 144 | 9 | 3574_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.33e-06 | 195 | 144 | 9 | 3408_DN | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 5.11e-06 | 199 | 144 | 9 | 5960_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 2.49e-05 | 186 | 144 | 8 | 4463_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.49e-05 | 186 | 144 | 8 | 3279_DN | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.01e-05 | 191 | 144 | 8 | 4217_DN | |
| Drug | 5152487; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.25e-05 | 193 | 144 | 8 | 896_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 3.37e-05 | 194 | 144 | 8 | 3570_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 2852_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 6770_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 3284_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 5091_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 1686_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 7012_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 4831_UP | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 5481_DN | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 3521_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 3170_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 7398_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; HL60; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 1281_DN | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 5697_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 6941_UP | |
| Drug | hemi-BABIM | 1.14e-04 | 75 | 144 | 5 | CID000001281 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.23e-04 | 174 | 144 | 7 | 7530_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.92e-04 | 187 | 144 | 7 | 2896_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 10000uM; HL60; HG-U133A | 2.12e-04 | 190 | 144 | 7 | 410_UP | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 191 | 144 | 7 | 2850_DN | |
| Drug | isopropyl myristate | 2.23e-04 | 19 | 144 | 3 | CID000008042 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 192 | 144 | 7 | 4743_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.26e-04 | 192 | 144 | 7 | 1266_DN | |
| Drug | rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.33e-04 | 193 | 144 | 7 | 921_UP | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 193 | 144 | 7 | 7232_DN | |
| Drug | SeHCAT | 2.36e-04 | 4 | 144 | 2 | CID000123829 | |
| Drug | gamma-glutamyl-2-naphthylamide | 2.36e-04 | 4 | 144 | 2 | CID000164706 | |
| Drug | AC1MI013 | 2.36e-04 | 4 | 144 | 2 | CID003035820 | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 7468_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 6102_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 3807_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 6921_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HG-U133A | 2.41e-04 | 194 | 144 | 7 | 409_UP | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 2.41e-04 | 194 | 144 | 7 | 1947_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 1264_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 6626_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 5424_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 7087_UP | |
| Drug | Econazole nitrate [24169-02-6]; Up 200; 9uM; HL60; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 2396_UP | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 6799_DN | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 4502_DN | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; HL60; HT_HG-U133A | 2.48e-04 | 195 | 144 | 7 | 2500_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 3971_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 7400_UP | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 5323_UP | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 2818_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 4697_DN | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 5668_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 3420_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 5734_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 6229_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 5449_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 3039_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 2887_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 2814_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 6237_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; HL60; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 2342_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.64e-04 | 197 | 144 | 7 | 1013_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 6306_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 1210_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 4315_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.64e-04 | 197 | 144 | 7 | 3610_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 1335_UP | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 1298_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 6242_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 3575_UP | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 6603_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.72e-04 | 198 | 144 | 7 | 1082_DN | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 2.72e-04 | 198 | 144 | 7 | 640_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 7317_UP | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 7428_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 6668_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 6043_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 5476_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 4979_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 4788_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 7190_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 5451_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 3107_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 7366_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 1330_UP | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 4215_DN | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 3465_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 6327_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.72e-04 | 198 | 144 | 7 | 3466_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.72e-04 | 198 | 144 | 7 | 842_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 144 | 7 | 7494_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.81e-04 | 199 | 144 | 7 | 2376_UP | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 144 | 7 | 7548_DN | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 144 | 7 | 4778_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A | 2.81e-04 | 199 | 144 | 7 | 4_DN | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 4.35e-07 | 4 | 142 | 3 | DOID:0111167 (implicated_via_orthology) | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 1.08e-06 | 5 | 142 | 3 | DOID:0060247 (implicated_via_orthology) | |
| Disease | mean arterial pressure | NAA60 WDR7 ERAP1 BBS2 TNS2 DBH ULK3 FURIN TRIM36 STK38L FYN ENPEP | 5.72e-06 | 499 | 142 | 12 | EFO_0006340 |
| Disease | subcortical band heterotopia (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:0111169 (is_implicated_in) | |
| Disease | knee injury | 6.88e-05 | 3 | 142 | 2 | EFO_0009507 | |
| Disease | tubulointerstitial nephritis antigen-like measurement | 6.88e-05 | 3 | 142 | 2 | EFO_0803197 | |
| Disease | Neurodevelopmental Disorders | 8.90e-05 | 93 | 142 | 5 | C1535926 | |
| Disease | systemising measurement | 1.36e-04 | 21 | 142 | 3 | EFO_0010221 | |
| Disease | Subcortical Band Heterotopia | 1.37e-04 | 4 | 142 | 2 | C1848201 | |
| Disease | anencephaly (is_implicated_in) | 1.37e-04 | 4 | 142 | 2 | DOID:0060668 (is_implicated_in) | |
| Disease | intellectual disability (is_implicated_in) | 4.03e-04 | 30 | 142 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | phosphate measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0010968 | |
| Disease | remission | 4.75e-04 | 7 | 142 | 2 | EFO_0009785 | |
| Disease | cannabis dependence | 5.05e-04 | 135 | 142 | 5 | EFO_0007191 | |
| Disease | diet measurement | MGAM IP6K3 DSCAM ACSM1 LAMA2 TENM2 NBAS ARID1B TENM4 NF1 MAP4K5 KLHDC8A FURIN MTMR2 | 5.57e-04 | 1049 | 142 | 14 | EFO_0008111 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.64e-04 | 152 | 142 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | protein eva-1 homolog C measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0801942 | |
| Disease | Unipolar Depression | 1.63e-03 | 259 | 142 | 6 | C0041696 | |
| Disease | triacylglycerol 48:4 measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0010407 | |
| Disease | glycerate measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0021029 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.58e-03 | 195 | 142 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | myopia (is_implicated_in) | 2.64e-03 | 16 | 142 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 2.64e-03 | 16 | 142 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 2.64e-03 | 16 | 142 | 2 | C1257877 | |
| Disease | ankle brachial index | 2.64e-03 | 16 | 142 | 2 | EFO_0003912 | |
| Disease | Myeloid Leukemia | 3.35e-03 | 18 | 142 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.35e-03 | 18 | 142 | 2 | C0023466 | |
| Disease | HETE measurement | 3.35e-03 | 62 | 142 | 3 | EFO_0801166 | |
| Disease | fish consumption measurement | 3.67e-03 | 64 | 142 | 3 | EFO_0010139 | |
| Disease | cerebral microbleeds | 3.73e-03 | 19 | 142 | 2 | EFO_0010059 | |
| Disease | Pheochromocytoma | 3.73e-03 | 19 | 142 | 2 | C0031511 | |
| Disease | Vertigo | 4.64e-03 | 139 | 142 | 4 | HP_0002321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYTGSGYRIRDSELQ | 21 | Q5TYW2 | |
| SSYFVIGAVLYRTLG | 811 | O60241 | |
| GSTVFRAILDYYKTG | 221 | Q9BSF8 | |
| VYTGSGYRIRDSELQ | 21 | Q5CZ79 | |
| RGTGVYLFYNKVRKT | 366 | Q9H7T0 | |
| VYTGSGYRIRDSELQ | 21 | Q4UJ75 | |
| YIGGYIFLSTRSKDQ | 646 | Q9BQL6 | |
| IFSLLSKYATGIRYT | 141 | Q9UKA4 | |
| ESEFYRLRLGTYQGN | 391 | O95841 | |
| SRQEKFYATLVRYVG | 2176 | Q8NFD5 | |
| KKARQEGGYRSEITY | 1146 | Q7Z478 | |
| YSKIRTRGSNYRFEG | 551 | Q03468 | |
| NRYYLRKDSLSVGVS | 371 | Q96BY7 | |
| SRFLIQSVKIGRGYF | 56 | Q8IWA6 | |
| GQERFKTITTAYYRG | 66 | P51153 | |
| GQERFRTITSSYYRG | 66 | Q9H0U4 | |
| RSYSRGAQGVILVYD | 81 | Q8WXH6 | |
| RSYSRGAQGVILVYD | 81 | Q12829 | |
| RSYSRGAQGVILVYD | 81 | P0C0E4 | |
| KVDSYGGSLRYNVRY | 606 | P98160 | |
| GQERFRTITSTYYRG | 66 | Q15286 | |
| GQERFRTITTAYYRG | 66 | P61006 | |
| GQERFRTITTAYYRG | 66 | Q92930 | |
| DIEGLYSKVRSRYSF | 1981 | Q92621 | |
| VYTGSGYRIRDSELQ | 21 | Q5SQ80 | |
| YRRGISYFGQLKFSD | 311 | Q6IE37 | |
| TSGYVRFYTENGVLL | 161 | Q9H2M9 | |
| SRYTLGKIYFIGFQR | 16 | P59103 | |
| TYYADSVKGRFTISR | 76 | A0A0C4DH42 | |
| GSTYYADSVKGRFTI | 76 | A0A075B6Q5 | |
| RYFRSIFEGGATELY | 126 | Q86U70 | |
| YRERAKALGYITSNF | 746 | Q68CZ1 | |
| AITYRTIGGILDFYV | 291 | Q2M2H8 | |
| QYRVGTDRTGFTFKY | 41 | P33992 | |
| SIRGVLKDGFTYVLY | 166 | Q9H7X0 | |
| LGRTITSKEVYFYTG | 236 | Q9UN88 | |
| AITYRTIGGILDFYV | 336 | O43451 | |
| REKTTIAVTSRGYYG | 201 | Q5HYC2 | |
| YDATRNVYRIISIGG | 41 | Q9NSC5 | |
| GRVYVYRLSEQDGSF | 546 | P38570 | |
| GFYKSTYRTKEGELR | 161 | Q9NZ08 | |
| YGGFLRRQFKVVTRS | 226 | P01213 | |
| RLIFTYGLTNSGKTY | 146 | Q96Q89 | |
| VRGTLTVTNYRLYFK | 101 | Q13614 | |
| LVGQYSTGKTTFIRY | 66 | Q9H223 | |
| TRRYYYSVKDISVGG | 271 | P24043 | |
| YTREGNLRYSAKSLF | 76 | Q9Y546 | |
| LNGSLVGFYRTTYTE | 196 | Q07075 | |
| DTFYRRGISYFGTLK | 336 | Q6IE36 | |
| YGRKLSVEGFRQALY | 271 | Q96PC2 | |
| YRGELRSYLVSVGTN | 206 | A2RRP1 | |
| GGRTTITTKKYRTQY | 541 | Q8WVV4 | |
| GDGSRTRQALVIYYS | 316 | Q7RTS6 | |
| FRFAKYYKINGTTTR | 301 | Q9UBL9 | |
| LYKYTLDEFGTARRS | 261 | Q9Y2V7 | |
| KYVGVAFYNVGRSLT | 136 | Q96A29 | |
| SKFLNIYSATYGRRT | 181 | P58658 | |
| VYTGSGYRIRDSELQ | 21 | Q5VUR7 | |
| SVGQKRVLRYYLFQG | 156 | Q9NQ11 | |
| LGSRFRYSGKTEYQT | 341 | Q9HCM4 | |
| YAIYTQRVRGGKIFI | 81 | O75054 | |
| NIVRLRYFFYSSGEK | 171 | P49840 | |
| LSNGTVGVYDKTSRY | 221 | Q9BXC9 | |
| NYTVFYSISGRGVDK | 166 | Q14574 | |
| FDGVYISKTTYIRQG | 266 | Q9UK97 | |
| KQLFLQTYARGRTTY | 956 | P53621 | |
| LQLRSGFSFRGVKVY | 736 | P09958 | |
| RKLDNGGYYITTRAQ | 206 | P06241 | |
| VRYIYTIDGSRKIGS | 101 | O43602 | |
| SSGIRLYYTAKLRRF | 346 | P09172 | |
| GYRTALRTFELDGYQ | 386 | Q6V0L0 | |
| ISGVGTRNYYRKIGY | 521 | Q9H9T3 | |
| GSIYKKAVYRRFTDG | 71 | Q6MZM0 | |
| KAVYRRFTDGTYSIE | 76 | Q6MZM0 | |
| YGFTIRAIRVYVGDS | 1151 | O15021 | |
| GLYFLRTKNGVVYQT | 66 | Q8WWU7 | |
| YYAIGKRSSETYRVT | 216 | Q14314 | |
| RLIYTAGGYFRQSLS | 326 | Q14145 | |
| YAATSFLRGSKIYVL | 166 | Q8IYD2 | |
| TNRVLSLGYRTKYTA | 321 | O00219 | |
| YIYGVSDNGRKYTRV | 651 | O00423 | |
| LYVVSENGRKYSRYG | 701 | Q9HC35 | |
| KYYRQVDTGNTGRVL | 21 | P42566 | |
| LRGSFTEYREFYKSL | 106 | Q58FG1 | |
| DIVRKSGGRKYTYRF | 306 | O00321 | |
| RYLQKGYTTLLFQEG | 591 | Q92902 | |
| TYKGLRIFYQDSVGV | 51 | Q5EB52 | |
| NSRGKNVARGRLTYY | 301 | Q9P232 | |
| NIVAYFGSYLSREKL | 76 | Q9Y4K4 | |
| YTFYVKAEDGGRVSR | 671 | Q9BZA8 | |
| ATVYGKGVYFARRAS | 911 | Q53GL7 | |
| TYYADSVKGRFTISR | 76 | P01767 | |
| RVRTATGYSGYSQKF | 516 | Q9UF33 | |
| GLLVDQSKIYSRAFY | 441 | O15403 | |
| SNFVSYVGKVATGRY | 256 | Q9H300 | |
| KTYLGEEGKRVRNYF | 101 | Q9BV86 | |
| SNRYGTAKVIGRLYV | 296 | O60469 | |
| FGRSTLVGTYTINYL | 1071 | Q2WGJ9 | |
| GRISFALRYLYGSDQ | 301 | Q9BQG1 | |
| RTYTVAVYFKGERIG | 1296 | Q9NRR4 | |
| INYTYKRFEGLTARG | 441 | Q15208 | |
| SSTYAFRVRAYKGSI | 481 | Q9NQ86 | |
| GGYYDTRKSRLELQK | 666 | Q9UQE7 | |
| YTYKRFEGLTQRGSI | 441 | Q9Y2H1 | |
| GQESTRRIGDYKVKY | 236 | Q15750 | |
| GFKRAFIITGQTYTR | 231 | P30566 | |
| GGSFITKVFRSRDYQ | 151 | Q8IY81 | |
| VQYYYDGLGRRVASK | 2246 | Q9UKZ4 | |
| KYGYTITRQDGTFDL | 956 | Q9NT68 | |
| LVTIYRSFKRVGASY | 96 | Q9HB58 | |
| FSIEGNRLTYEKRYS | 536 | P35498 | |
| YGFQITAYFLKRGIR | 81 | Q5VYV7 | |
| TSAGIKIYQRFYTTR | 506 | Q8IZF2 | |
| KRRTGLLLYENYGQS | 356 | Q08AH1 | |
| FREKGGYRTTTVIFY | 81 | Q8WUX2 | |
| YRIGQSKIFFRTGVL | 761 | P35749 | |
| AVFGGYYIRLLVTSQ | 291 | Q5VZI3 | |
| GTYNAYRIIATTEGL | 156 | P25874 | |
| DSFQKVILRRYGKYG | 126 | Q14593 | |
| NTLVYYKLEGGRRVT | 31 | Q9NYT0 | |
| FRYLISYGEFGNVTR | 306 | Q5M7Z0 | |
| SRTVFRKVGGFVYIT | 641 | Q8IZQ1 | |
| IDGGLYTATRYEFRS | 176 | Q9NTN9 | |
| YRADGIRIYKISSGS | 1946 | Q99973 | |
| TEQSFGLYGNKYTLR | 906 | O60673 | |
| TKYGFYARTDARQGV | 341 | Q9UGH3 | |
| LGYLYFRDRTGDTFR | 496 | Q6P1M0 | |
| FYRGRYVLGEETTKS | 466 | Q8IXW5 | |
| SLREAVRTFVGYGYN | 1036 | Q15413 | |
| LTQGTNGRYKTKYRS | 651 | Q6ZMY3 | |
| YEIELYGISKGRRSQ | 1686 | P24821 | |
| YSGKQTFYVTLRYGR | 181 | Q96B77 | |
| FYYVARRFKTGQING | 1606 | P21359 | |
| TLLFAYFSSRKRYGV | 1286 | Q92576 | |
| SIYAFRGLNSLTKLY | 166 | Q9HBX9 | |
| TFYLGTGRRVIYKYG | 2001 | Q6N022 | |
| SRYQDILVFRSKTYG | 46 | P19623 | |
| RTKTVQGYRLTNAGY | 66 | Q9BVS4 | |
| LYRQSSKLYGSIFTG | 196 | Q63HK5 | |
| TKIYVLDYLGTVRFG | 286 | Q6PKC3 | |
| YVKLARSLRTYGVSF | 301 | Q9Y4G6 | |
| STYRGTYEQDGRFEK | 226 | Q96N95 | |
| TRGVTGYFTFNLYLK | 131 | Q15238 | |
| FVFTYKGLRALQSYI | 81 | Q9Y6I8 | |
| VSARYDQRYLISGGV | 476 | Q9Y4E6 | |
| RRYISYFSGLLSGSI | 281 | Q63HR2 | |
| YSLRFSVGYTVEKNG | 171 | O75795 | |
| LTERLGSGTYATVYK | 16 | Q6PHR2 | |
| GYDRRFYTEILNGLK | 86 | Q5VZ52 | |
| GRTKRYVVFNNGTLY | 2296 | Q9NR99 | |
| TKFVLRYLTESYGTG | 161 | Q9UM54 |